Safety data sheet. GHS / OSHA HCS 2012 format, 16 sections. Issued by Epic Peptides Lab for the catalogue items listed in Section 1.

Epic Peptides Lab

Safety data sheet · capsules

Epic Peptides Lab · USA

Document number
PL-SDS-022
Revision
1.0 · 2026-10-03

BPC-157

capsules

1Identification

Product Identifier
BPC-157
Document Number
PL-SDS-022
Catalogue Items Covered
  • Id
    2843
    Name
    BPC-157 Capsules (60/500mcg)
    Sku
    PL-BPC157-500MCG-CAP
Recommended Use
Laboratory research use by trained personnel.
Restrictions On Use
Not for human or veterinary use.
Supplier / Distributor
Epic Peptides Lab, USA
Telephone
+1 (787) 468-5291
Email
info@epicpeptideslab.com

2Hazard(s) identification

Classification
Not classified as hazardous under OSHA HCS 2012 (29 CFR 1910.1200) or UN GHS, on the basis of the supplier safety data sheets consulted.
Label Elements
No data available.
Signal Word
No data available.
Other Hazards
No data available.

3Composition / information on ingredients

Description
Hard gelatin capsules containing the active substance blended with microcrystalline cellulose, packed in a sealed bottle.
Composition
  • Name
    BPC-157
    Full
    Body Protection Compound-157; pentadecapeptide
    Cas
    137525-51-0
    Formula
    C62H98N16O22
    Conc
    as labelled
    Qty
    as labelled
  • Name
    Microcrystalline cellulose
    Full
    Microcrystalline cellulose (capsule filler)
    Cas
    9004-34-6
    Formula
    (C6H10O5)n
    Conc
    balance of capsule contents
  • Name
    Gelatin
    Full
    Gelatin (capsule shell)
    Cas
    9000-70-8
    Conc
    capsule shell

4First-aid measures

First Aid Measures
Inhalation
Move the person to fresh air and keep comfortable for breathing. If breathing is difficult or symptoms persist, call a POISON CENTER or doctor.
Skin
Take off contaminated clothing. Wash the skin with plenty of soap and water. If irritation or a rash develops, get medical advice.
Eyes
Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do; continue rinsing. If eye irritation persists, get medical advice.
Ingestion
Rinse mouth. Do not induce vomiting. Call a POISON CENTER or doctor if you feel unwell.
Most Important Symptoms And Effects
No specific symptoms are known. Pharmacologically active material: systemic effects consistent with its mechanism of action are possible after accidental injection, ingestion or absorption.
Likely Routes Of Exposure
Ingestion; inhalation of dust and skin/eye contact if capsules are opened.

5Fire-fighting measures

Fire Fighting Information
Combustible organic solid; capsule contents may form combustible dust if dispersed in bulk.

6Accidental release measures

Spill And Clean Up Procedures
Collect intact capsules. Dampen any spilled powder with water, wipe up with absorbent material and place in a sealed container for disposal.

7Handling and storage

Safe Handling
Do not open or crush capsules unless required for an experiment; if capsule contents are handled as a powder, avoid generating dust and weigh inside a ventilated enclosure. Wash hands after handling.
Safe Storage
Store at room temperature (15–25 °C) in the tightly closed original container, dry and protected from light.
Storage Temperature
15–25 °C, dry, protected from light
Incompatible Materials
No further relevant information available (Cayman). Generic for peptides: strong oxidizing agents, strong acids/bases

8Exposure controls / personal protection

Occupational Exposure Limits
  • Microcrystalline cellulose: OSHA PEL 15 mg/m³ (total dust), 5 mg/m³ (respirable fraction); ACGIH TLV 10 mg/m³ (as cellulose).
  • No occupational exposure limits have been established for the active ingredient(s).
Exposure Controls And PPE
No data available.

9Physical and chemical properties

Physical State
Solid
Appearance
Hard gelatin capsules containing a white to off-white powder
Properties
Odor
Characteristic (Cayman); threshold not determined
Ph
Not applicable (solid)
Melting
Undetermined
Boiling
Undetermined
Flash
Not applicable (non-flammable solid); combustible organic material
Vapour
Negligible (solid)
Density
No data available (bulk density of lyophilized cake is low)
Solubility
Not determined in Cayman SDS; supplier product page gives no solubility figure. Generally water-soluble peptide
Logp
No data available
Decomp
No data available; peptides decompose above about 200 °C
Other
Not flammable (Cayman). Sequence GEPPPGKPADDAGLV; C62H98N16O22, FW 1419.5 (free peptide); Cayman SDS is for the acetate salt CAS 1628202-19-6 (free peptide CAS 137525-51-0)

10Stability and reactivity

Stability And Reactivity
Reactivity
No dangerous reactions known; no decomposition if used according to specifications
Incompatible
No further relevant information available (Cayman). Generic for peptides: strong oxidizing agents, strong acids/bases
Decomposition
No dangerous decomposition products known (Cayman). Thermal decomposition of peptides generally yields carbon oxides and nitrogen oxides
Conditions To Avoid
No further relevant information available; store at -20 °C, desiccated, protected from light per product spec
Conditions To Avoid
No data available.
Incompatible Materials
No data available.

11Toxicological information

Toxicological Information
  • Acute toxicity, oral

    No data available

  • Acute toxicity, dermal

    No data available

  • Acute toxicity, inhalation

    No data available

  • Skin corrosion/irritation

    No irritant effect (Cayman)

  • Serious eye damage/irritation

    No irritating effect (Cayman)

  • Respiratory or skin sensitisation

    No sensitizing effects known (Cayman)

  • Germ cell mutagenicity

    No data available

  • Carcinogenicity

    Not listed by IARC, NTP or OSHA (Cayman)

  • Reproductive toxicity

    No data available

  • STOT, single exposure

    No data available

  • STOT, repeated exposure

    No data available

  • Aspiration hazard

    No data available

Routes Of Exposure
Ingestion; inhalation of dust and skin/eye contact if capsules are opened.
Symptoms
No specific symptoms are known. Pharmacologically active material: systemic effects consistent with its mechanism of action are possible after accidental injection, ingestion or absorption.

12Ecological information

Ecological Information
Cayman: Water hazard class 1 (self-assessment), slightly hazardous for water; no aquatic toxicity, persistence or bioaccumulation data available.

13Disposal considerations

Disposal Guidance
No data available.

14Transport information

Transport Classification
Note
Not regulated as a dangerous good for transport by road (DOT 49 CFR), air (IATA/ICAO) or sea (IMDG). Not a marine pollutant. Ship refrigerated or frozen as required by Section 7; the coolant (dry ice, UN 1845) is regulated when used.

15Regulatory information

Regulatory Information
Tsca
Substance is not listed (Cayman)
Carcinogen Listings
Not listed by IARC, NTP, OSHA or EPA
Dea
Not a controlled substance
Other
Not listed under SARA 313 or as a HAP (Cayman). Not an approved drug in any jurisdiction. FDA placed BPC-157 on the 503A bulk-substances Category 2 list (substances that may present significant safety risks for compounding) in 2023 - verify current status. WADA remark: BPC-157 is named as an example under S0 (non-approved substances) on the WADA Prohibited List.
Carcinogen Listings
No data available.

16Other information

Revision
October 3, 2026
Sources Consulted
  • Cayman Chemical
  • Cayman Chemical product page
  • Spectrum Chemical
  • Sigachi Industries
  • Parchem
  • Fisher Scientific / Acros Organics
  • Electron Microscopy Sciences
Confidence
high
Additional Information
  • Named under WADA class S0 (non-approved substances).
Back to SDS list
JOIN THE Epic Peptides Lab
Exclusive access for verified researchers only.

Enter your details to access our catalog, COA library,
and research compound database.

By submitting you agree to receive email communications from Epic Peptides Lab You can unsubscribe at any time. All products for in vitro research use only.

15% off any order

Restock alerts, new compounds and fresh lab results.
We’ll email your code straight away – 15% off, one-time use.

Research updates only. Unsubscribe any time.